SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-025087
Filing Date
2020-05-13
Accepted
2020-05-13 16:31:43
Documents
66
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sdgr-10q_20200331.htm 10-Q 2522202
2 EX-31.1 sdgr-ex311_11.htm EX-31.1 15795
3 EX-31.2 sdgr-ex312_10.htm EX-31.2 15787
4 EX-32.1 sdgr-ex321_9.htm EX-32.1 5788
5 EX-32.2 sdgr-ex322_8.htm EX-32.2 5924
  Complete submission text file 0001564590-20-025087.txt   7040320

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sdgr-20200331.xml EX-101.INS 1231179
7 XBRL TAXONOMY EXTENSION SCHEMA sdgr-20200331.xsd EX-101.SCH 51716
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sdgr-20200331_cal.xml EX-101.CAL 50852
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sdgr-20200331_def.xml EX-101.DEF 202483
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sdgr-20200331_lab.xml EX-101.LAB 390169
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sdgr-20200331_pre.xml EX-101.PRE 315240
Mailing Address 120 WEST 45TH STREET 17TH FLOOR NEW YORK NY 10036
Business Address 120 WEST 45TH STREET 17TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Filer) CIK: 0001490978 (see all company filings)

IRS No.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39206 | Film No.: 20873618
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences